Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Clinical Trial to Examine the Improvement of E Balance Pro Therapy on Diabetes and Related Complications

NCT03172260 is registered in ClinicalTrials.gov with CellMedX Corporation as lead sponsor.

NCT NCT03172260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03172260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Clinical Trial to Examine the Improvement of E Balance Pro Therapy on Diabetes and Related Complications
Lead sponsor
CellMedX Corporation
Phase
Observational
Overall status
Completed
Start date
February 8, 2017
Completion date
July 20, 2017
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes